Search Results
Oct 01, 2025, 08:00 ET RheumaGen Announces Oral Presentation on HLA Gene-Editing Preclinical Data for Lead Autoimmune Disease Program at ACR Convergence 2025
Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human leukocyte antigen (HLA) gene-editing abstract has been selected for oral presentation at the American College
More news about: RheumaGen, Inc.
Oct 01, 2025, 08:00 ET Sentynl Therapeutics updates on its NDA for CUTX-101
About Menkes Disease Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A. The minimum birth prevalence for Menkes disease is believed to be 1 in 34,810 live male births, and potentially
More news about: Sentynl Therapeutics
Oct 01, 2025, 06:55 ET Corteva Announces Plan to Separate into Two Industry-Leading Public Companies
will include targeted M&A, sustained investment in R&D and the fulfillment of existing opportunities: out-licensing, hybrid wheat, biofuels and gene editing. By consistently delivering value to farmers and shareholders alike, SpinCo will deliver its next phase of innovation-driven
More news about: Corteva, Inc.
Oct 01, 2025, 06:30 ET PROSPERITY BANCSHARES, INC.® TO ACQUIRE SOUTHWEST BANCSHARES, INC. IN SAN ANTONIO, TEXAS
In addition, upon completion of the merger, Gene Dawson, Jr., Interim Chairman, President and Chief Executive Officer of Southwest, will join the Board of Directors of Prosperity Bank. "It has been a pleasure getting to know Gene, Brent, Tom and the management team at Southwest.
More news about: Prosperity Bancshares, Inc.
Oct 01, 2025, 06:03 ET Karmanos Thinks Pink, Recognizes Breast Cancer Awareness Month in October
of male breast cancer are estimated in the U.S. in 2025. Approximately 5%-10% of breast cancers can be linked to inherited gene mutations. All data reported by the American Cancer Society.
More news about: Karmanos Cancer Institute
Sep 30, 2025, 21:50 ET GROUNDBREAKERS 2025: Prologis CEO, Secretary Burgum Headline Forum Focusing on Energy Reliability, AI and the Future of Global Supply Chains
The customer is changing every quarter," said Jane. 2028 Summer Olympic Games: Gene Sykes (U.S. Olympic & Paralympic Committee) and Matt Wikstrom (U.S. Olympic and Paralympic Properties) joined Will O'Donnell (Prologis)
More news about: Prologis, Inc.
Sep 30, 2025, 14:09 ET CeraVe 與 L'Oréal Groupe 憑藉突破性頭皮屑研究榮獲 IFSCC Applied Research Award
L'Oréal 的 CeraVe 醫療事務及傳訊全球高級副總裁 Gene Colón表示：「我們獲頒 IFSCC Applied Research，證明我們共同履行科學創新與探討皮膚和頭皮屏障健康複雜生物學的承諾。這項變革研究超越傳統頭皮屑觀點，並強調神經酰胺缺乏和頭皮屏障功能障礙、關鍵細菌成份與種族的影響。它大幅擴展我們根植於基礎神經酰胺科學的科學理解，並為未來創新提供全新視角和可能。」
More news about: CeraVe
Sep 30, 2025, 13:54 ET Emily Whitehead Foundation Expands Mission Beyond Pediatric Cancer: Supporting All Individuals with Cancer and Rare Diseases
revolutionary CAR T-cell therapy that saved Emily's life," said Tom Whitehead, co-founder of the Emily Whitehead Foundation. "As the field of cell and gene therapies has rapidly advanced, we've seen the incredible potential of these innovative treatments to transform lives across a wider spectrum of diseases.
More news about: Emily Whitehead Foundation
Sep 30, 2025, 11:45 ET Made Scientific and Syenex Forge Technology Partnership to Transform T Cell Therapy Manufacturing
and efficiency of engineered T cell therapies through the use of Syenex's bioengineering systems, UltraCell™ and RapidCell™, providing improvement in gene delivery efficiency and engineering timelines.
More news about: Made Scientific, Inc.
Sep 30, 2025, 11:34 ET CeraVe y L'Oréal Groupe ganan el prestigioso Premio de Investigación Aplicada de IFSCC
conjunto con la innovación científica y la comprensión de la compleja biología de la salud de la barrera cutánea y del cuero cabelludo", afirmó Gene Colón, vicepresidente sénior global de Asuntos Médicos y Comunicaciones de CeraVe en L'Oréal. "Esta investigación revolucionaria trasciende la
More news about: CeraVe
Sep 30, 2025, 10:59 ET CeraVe e L'Oréal Groupe ganham o prestigioso IFSCC Applied Research Award pelo Breakthrough Dandruff Study
compromisso conjunto com a inovação científica e a compreensão da intrincada biologia da saúde da barreira da pele e do couro cabeludo", disse Gene Colón, Vice-Presidente Sênior Global de Assuntos Médicos e Comunicações da CeraVe na L'Oréal. "Esta pesquisa revolucionária vai além da visão
More news about: CeraVe
Sep 30, 2025, 10:43 ET CeraVe y L'Oréal Groupe ganan el prestigioso premio IFSCC Applied Research Award por su innovador estudio sobre la caspa
conjunto con la innovación científica y la comprensión de la intrincada biología de la salud de la barrera de la piel y el cuero cabelludo", dijo Gene Colón, Vicepresidente Senior Global de CeraVe en L'Oréal. "Esta investigación revolucionaria va más allá de la visión tradicional de la caspa
More news about: CeraVe
Sep 30, 2025, 10:27 ET CeraVe und L'Oréal Groupe gewinnen prestigeträchtigen IFSCC-Preis für angewandte Forschung für bahnbrechende Schuppenstudie
unser gemeinsames Engagement für wissenschaftliche Innovation und das Verständnis der komplexen Biologie der Haut- und Kopfhautbarriere", sagte Gene Colón, Global Senior Vice President, Medical Affairs & Communications für CeraVe bei L'Oréal. „Diese bahnbrechende Forschungsarbeit geht
More news about: CeraVe
Sep 30, 2025, 08:34 ET Gene Juarez Expands Beyond Western Washington with Spokane Opening
About Gene Juarez Salons & Spas: Gene Juarez is a trusted leader in beauty and wellness, offering elevated salon and spa services that blend artistry with modern innovation. Established in 1971 by visionary stylist Gene Juarez, the brand began with a mission to
More news about: Gene Juarez
Sep 30, 2025, 08:34 ET Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro - Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features
ChIP-seq data - without significant time investment," says Björn Reinius, Associate Professor at the Karolinska Institute with a research focus on gene dosage compensation. "With minimal optimization, the protocol enables users to generate quantitative ChIP-seq libraries and to perform preliminary
More news about: Epigenica AB
Sep 30, 2025, 08:33 ET CeraVe et L'Oréal Groupe remportent le prestigieux prix de la recherche appliquée de l'IFSCC pour une étude révolutionnaire sur les pellicules
de l'innovation scientifique et de la compréhension de la biologie complexe de la santé de la barrière cutanée et du cuir chevelu », a déclaré Gene Colón, Global Senior Vice President, Medical Affairs & Communications for CeraVe at L'Oréal. « Cette recherche révolutionnaire va au-delà
More news about: CeraVe
Sep 30, 2025, 08:30 ET Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership
"This LOI marks a transformative step for Klotho," said Dr. Joseph Sinkule, CEO of Klotho Neurosciences. "The Klotho gene is often referred to as the 'anti-aging gene,' first identified for its ability to extend lifespan in animal models and protect against neurodegenerative diseases. Our company
More news about: Klotho Neurosciences, Inc.
Sep 30, 2025, 08:30 ET Bionique Testing Laboratories Strengthens Operations with ~35,000 Sq Ft Expansion to further support drug development and demand for rapid biosafety testing solutions
development and processing. It also includes flexible containment labs and BSL capabilities to meet diverse modality needs across biologics, cell and gene therapies, and advanced therapeutics. The expansion increases capacity for high-volume, CGMP-compliant lot-release workflows with optimized sample logistics
More news about: Bionique Testing Laboratories LLC
Sep 30, 2025, 07:27 ET Kexing Biopharm's Sorafenib Generic Receives Approvals in Egypt and Peru
in the research, manufacture, and commercialization of innovative medicines combining recombinant proteins, antibodies, and next generation cell and gene therapies. Harnessing proprietary technology platforms, Kexing pioneers novel targeted biological therapies and advanced drug delivery systems to address
More news about: Kexing Biopharm
Sep 30, 2025, 05:00 ET US Department of Energy Validates Commonwealth Fusion Systems' Successful Completion of Magnet Technology Performance Test and Energy Secretary Chris Wright Visits SPARC, the World's Most Advanced Next-Generation Energy Technology Project
multimedia:https://www.prnewswire.com/news-releases/us-department-of-energy-validates-commonwealth-fusion-systems-successful-completion-of-magnet-technology-performance-test-and-energy-secretary-chris-wright-visits-sparc-the-worlds-most-advanced-next-generation-energy-technology-302570322.html
More news about: Commonwealth Fusion Systems
Sep 30, 2025, 02:34 ET Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro - Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features
ChIP-seq data - without significant time investment," says Björn Reinius, Associate Professor at the Karolinska Institute with a research focus on gene dosage compensation. "With minimal optimization, the protocol enables users to generate quantitative ChIP-seq libraries and to perform preliminary
More news about: Epigenica AB
Sep 29, 2025, 13:48 ET Vantage Market Research: Global Companion Diagnostics Market Size & Share to Surpass USD 31.75 Billion by 2035, Growing at a CAGR 11.75% | Powering Precision Medicine, Targeted Therapies and Next-Gen Drug Development
targeted cancer therapies. Chronic & Rare Diseases: Expansion of CDx-guided biologics and gene therapies. Drug Development Efficiency: Pharma leveraging CDx to boost clinical trial success
More news about: Vantage Market Research
Sep 29, 2025, 11:21 ET Contagem regressiva para o verão: é hora de cuidar da pele para chegar com tudo no período de festas e férias
Skin Quality. Dermatol Surg. Jan 2019. 45; 718-24 8. Waibel J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and calcium hydroxylapatite (CaHA) in the treatment of nasolabial folds. Poster presented at the IMCAS World
More news about: Galderma
Sep 29, 2025, 10:18 ET METiS Launches World's First AI-Driven Nano-Delivery Platform NanoForge
nano-delivery now allows precise control over targeting, release kinetics, and immunogenicity—making it essential to advances in mRNA cancer therapies, gene editing, protein replacement, and other cutting-edge modalities. About METiS TechBio Unlocking a healthier
More news about: METiS TechBio
Sep 29, 2025, 08:30 ET Solutions For Recombinant Protein Expression, Upcoming Webinar Hosted by Xtalks
recombinant protein expression through gene design, host selection and process optimization. Attendees will learn about the pros and cons of alternative expression hosts. The featured speakers will share insights about increasing translational efficiency through reloaded gene sequences. Attendees will learn
More news about: Xtalks